Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization

PLoS Pathogens

Volumn 6, Issue 6, 2010, Pages

  Smith, Jason G ^a,d   Silvestry, Mariena ^b   Lindert, Steffen ^b   Lu, Wuyuan ^c   Nemerow, Glen R ^a   Stewart, Phoebe L ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFENSIN; ALPHA DEFENSIN; ANTIINFECTIVE AGENT; CAPSID PROTEIN;

ADENOVIRUS; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; VIRUS NEUTRALIZATION; ADENOVIRUS INFECTION; AMINO ACID SEQUENCE; CELL CULTURE; CHEMISTRY; CLASSIFICATION; CRYOELECTRON MICROSCOPY; DRUG EFFECT; FLOW CYTOMETRY; HUMAN ADENOVIRUS; METABOLISM; MOLECULAR GENETICS; PATHOGENICITY; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY; VIRION; VIROLOGY; VIRUS ASSEMBLY; VIRUS REPLICATION;

ADENOVIRIDAE; HUMAN ADENOVIRUS; MIRIDAE;

ADENOVIRIDAE INFECTIONS; ADENOVIRUSES, HUMAN; ALPHA-DEFENSINS; AMINO ACID SEQUENCE; ANTI-INFECTIVE AGENTS; CAPSID PROTEINS; CELLS, CULTURED; CRYOELECTRON MICROSCOPY; FLOW CYTOMETRY; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID; VIRION; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 77954682175     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000959     Document Type: Article

References (67)

1. Selsted ME, Ouellette AJ (2005) Mammalian defensins in the antimicrobial immune response. Nat Immunol 6: 551-557.
2. Lehrer RI (2007) Multispecific myeloid defensins. Curr Opin Hematol 14: 16-21.
3. Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3: 238-250.
4. Klotman ME, Chang TL (2006) Defensins in innate antiviral immunity. Nat Rev Immunol 6: 447-456.
5. Hazrati E, Galen B, Lu W, Wang W, Ouyang Y, et al. (2006) Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection. J Immunol 177: 8658-8666.
6. Wang W, Owen SM, Rudolph DL, Cole AM, Hong T, et al. (2004) Activity of alpha- and theta-defensins against primary isolates of HIV-1. J Immunol 173: 515-520.
7. Yasin B, Wang W, Pang M, Cheshenko N, Hong T, et al. (2004) Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J Virol 78: 5147-5156.
8. Bastian A, Schafer H (2001) Human alpha-defensin 1 (HNP-1) inhibits adenoviral infection in vitro. Regul Pept 101: 157-161.
9. Buck CB, Day PM, Thompson CD, Lubkowski J, Lu W, et al. (2006) Human alpha-defensins block papillomavirus infection. Proc Natl Acad Sci U S A 103: 1516-1521.
10. Dugan AS, Maginnis MS, Jordan JA, Gasparovic ML, Manley K, et al. (2008) Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells. J Biol Chem 283: 31125-31132.
11. Gropp R, Frye M, Wagner TO, Bargon J (1999) Epithelial defensins impair adenoviral infection: implication for adenovirus-mediated gene therapy. Hum Gene Ther 10: 957-964.
12. Harvey SA, Romanowski EG, Yates KA, Gordon YJ (2005) Adenovirus-directed ocular innate immunity: the role of conjunctival defensin-like chemokines (IP-10, I-TAC) and phagocytic human defensin-alpha. Invest Ophthalmol Vis Sci 46: 3657-3665.
13. Smith JG, Nemerow GR (2008) Mechanism of adenovirus neutralization by human alpha-defensins. Cell Host Microbe 3: 11-19.
14. Virella-Lowell I, Poirier A, Chesnut KA, Brantly M, Flotte TR (2000) Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients. Gene Ther 7: 1783-1789.
15. Benko M, Harrach B, Both GW, Russell WC, Adair BM, et al. (2005) Family Adenoviridae. In: Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA, eds. Virus Taxonomy VIIIth Report of the International Committee on Taxonomy of Viruses. New York: Elsevier. pp 213-228.
16. Jones MS, 2nd, Harrach B, Ganac RD, Gozum MM, Dela Cruz WP, et al. (2007) New adenovirus species found in a patient presenting with gastroenteritis. J Virol 81: 5978-5984.
17. Walsh MP, Chintakuntlawar A, Robinson CM, Madisch I, Harrach B, et al. (2009) Evidence of molecular evolution driven by recombination events influencing tropism in a novel human adenovirus that causes epidemic keratoconjunctivitis. PLoS One 4: e5635.
18. Walsh MP, Seto J, Jones MS, Chodosh J, Xu W, et al. (2010) Computational analysis identifies human adenovirus type 55 as a re-emergent acute respiratory disease pathogen. J Clin Microbiol 48: 991-993.
19. Arnberg N (2009) Adenovirus receptors: implications for tropism, treatment and targeting. Rev Med Virol 19: 165-178.
20. Stewart PL, Nemerow GR (2007) Cell integrins: commonly used receptors for diverse viral pathogens. Trends Microbiol 15: 500-507.
21. Greber UF, Willetts M, Webster P, Helenius A (1993) Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75: 477-486.
22. Nakano MY, Boucke K, Suomalainen M, Stidwill RP, Greber UF (2000) The first step of adenovirus type 2 disassembly occurs at the cell surface, independently of endocytosis and escape to the cytosol. J Virol 74: 7085-7095.
23. Wiethoff CM, Wodrich H, Gerace L, Nemerow GR (2005) Adenovirus protein VI mediates membrane disruption following capsid disassembly. J Virol 79: 1992-2000.
24. Leopold PL, Crystal RG (2007) Intracellular trafficking of adenovirus: many means to many ends. Adv Drug Deliv Rev 59: 810-821.
25. Rajabi M, de Leeuw E, Pazgier M, Li J, Lubkowski J, et al. (2008) The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability. J Biol Chem 283: 21509-21518.
26. Wu Z, Li X, de Leeuw E, Ericksen B, Lu W (2005) Why is the Arg5-Glu13 salt bridge conserved in mammalian alpha-defensins? J Biol Chem 280: 43039-43047.
27. Maemoto A, Qu X, Rosengren KJ, Tanabe H, Henschen-Edman A, et al. (2004) Functional analysis of the alpha-defensin disulfide array in mouse cryptdin-4. J Biol Chem 279: 44188-44196.
28. Wu Z, Hoover DM, Yang D, Boulegue C, Santamaria F, et al. (2003) Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc Natl Acad Sci U S A 100: 8880-8885.
29. Wei G, de Leeuw E, Pazgier M, Yuan W, Zou G, et al. (2009) Through the looking glass, mechanistic insights from enantiomeric human defensins. J Biol Chem 284: 29180-29192.
30. Saban SD, Nepomuceno RR, Gritton LD, Nemerow GR, Stewart PL (2005) CryoEM structure at 9A resolution of an adenovirus vector targeted to hematopoietic cells. J Mol Biol 349: 526-537.
31. Saban SD, Silvestry M, Nemerow GR, Stewart PL (2006) Visualization of alpha-helices in a 6-angstrom resolution cryoelectron microscopy structure of adenovirus allows refinement of capsid protein assignments. J Virol 80: 12049-12059.
32. Rux JJ, Kuser PR, Burnett RM (2003) Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methods. J Virol 77: 9553-9566.
33. Zubieta C, Schoehn G, Chroboczek J, Cusack S (2005) The structure of the human adenovirus 2 penton. Mol Cell 17: 121-135.
34. Kalyuzhniy O, Di Paolo NC, Silvestry M, Hofherr SE, Barry MA, et al. (2008) Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc Natl Acad Sci U S A 105: 5483-5488.
35. Waddington SN, McVey JH, Bhella D, Parker AL, Barker K, et al. (2008) Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132: 397-409.
36. Nguyen EK, Nemerow GR, Smith JG (2010) Direct evidence from single-cell analysis that human alpha-defensins block adenovirus uncoating to neutralize nnfection. J Virol 84: 4041-4049.
37. Roy S, Clawson DS, Calcedo R, Lebherz C, Sanmiguel J, et al. (2005) Use of chimeric adenoviral vectors to assess capsid neutralization determinants. Virology 333: 207-214.
38. Youil R, Toner TJ, Su Q, Chen M, Tang A, et al. (2002) Hexon gene switch strategy for the generation of chimeric recombinant adenovirus. Hum Gene Ther 13: 311-320.
39. Konz JO, Livingood RC, Bett AJ, Goerke AR, Laska ME, et al. (2005) Serotype specificity of adenovirus purification using anion-exchange chromatography. Hum Gene Ther 16: 1346-1353.
40. Lehrer RI, Jung G, Ruchala P, Wang W, Micewicz ED, et al. (2009) Human alpha-defensins inhibit hemolysis mediated by cholesterol-dependent cytolysins. Infect Immun 77: 4028-4040.
41. Manning JS, Hackett AJ, Darby NB, Jr. (1971) Effect of polycations on sensitivity of BALD-3T3 cells to murine leukemia and sarcoma virus infectivity. Appl Microbiol 22: 1162-1163.
42. Hill CP, Yee J, Selsted ME, Eisenberg D (1991) Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science 251: 1481-1485.
43. Szyk A, Wu Z, Tucker K, Yang D, Lu W, et al. (2006) Crystal structures of human alpha-defensins HNP4, HD5, and HD6. Protein Sci 15: 2749-2760.
44. Lehrer RI, Jung G, Ruchala P, Andre S, Gabius HJ, et al. (2009) Multivalent binding of carbohydrates by the human alpha-defensin, HD5. J Immunol 183: 480-490.
45. Ghosh D, Porter E, Shen B, Lee SK, Wilk D, et al. (2002) Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol 3: 583-590.
46. Ganz T, Selsted ME, Szklarek D, Harwig SS, Daher K, et al. (1985) Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest 76: 1427-1435.
47. Ganz T (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3: 710-720.
48. Ganz T (1987) Extracellular release of antimicrobial defensins by human polymorphonuclear leukocytes. Infect Immun 55: 568-571.
49. Faurschou M, Sorensen OE, Johnsen AH, Askaa J, Borregaard N (2002) Defensin-rich granules of human neutrophils: characterization of secretory properties. Biochim Biophys Acta 1591: 29-35.
50. Cotter MJ, Zaiss AK, Muruve DA (2005) Neutrophils interact with adenovirus vectors via Fc receptors and complement receptor 1. J Virol 79: 14622-14631.
51. Sherwood V, Burgert HG, Chen YH, Sanghera S, Katafigiotis S, et al. (2007) Improved growth of enteric adenovirus type 40 in a modified cell line that can no longer respond to interferon stimulation. J Gen Virol 88: 71-76.
52. Robinson CM, Shariati F, Zaitshik J, Gillaspy AF, Dyer DW, et al. (2009) Human adenovirus type 19: Genomic and bioinformatics analysis of a keratoconjunctivitis isolate. Virus Res 139: 122-126.
53. Smith TA, Idamakanti N, Rollence ML, Marshall-Neff J, Kim J, et al. (2003) Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice. Hum Gene Ther 14: 777-787.
54. Warming S, Costantino N, Court DL, Jenkins NA, Copeland NG (2005) Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res 33: e36.
55. Wodrich H, Henaff D, Jammart B, Segura-Morales C, Seelmeir S, et al. (2010) A Capsid-Encoded PPxY-Motif Facilitates Adenovirus Entry. PLoS Pathog 6: e1000808.
56. Cauthen AN, Welton AR, Spindler KR (2007) Construction of mouse adenovirus type 1 mutants. Methods Mol Med 130: 41-59.
57. Evans RK, Nawrocki DK, Isopi LA, Williams DM, Casimiro DR, et al. (2004) Development of stable liquid formulations for adenovirus-based vaccines. J Pharm Sci 93: 2458-2475.
58. de Leeuw E, Burks SR, Li X, Kao JP, Lu W (2007) Structure-dependent functional properties of human defensin 5. FEBS Lett 581: 515-520.
59. DeLano WL (2008) The PyMOL Molecular Graphics System. Palo Alto, CA, USA: DeLano Scientific LLC. pp. http://www.pymol.org.
60. Rasband WS (1997-2009) ImageJ. Bethesda, MD: U.S. National Institutes of Health. pp. http://rsb.info.nih.gov/ij/.
61. Nepomuceno RR, Pache L, Nemerow GR (2007) Enhancement of gene transfer to human myeloid cells by adenovirus-fiber complexes. Mol Ther 15: 571-578.
62. Henry LJ, Xia D, Wilke ME, Deisenhofer J, Gerard RD (1994) Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli. J Virol 68: 5239-5246.
63. Shi J, Williams DR, Stewart PL (2008) A Script-Assisted Microscopy (SAM) package to improve data acquisition rates on FEI Tecnai electron microscopes equipped with Gatan CCD cameras. J Struct Biol 164: 166-169.
64. Mindell JA, Grigorieff N (2003) Accurate determination of local defocus and specimen tilt in electron microscopy. J Struct Biol 142: 334-347.
65. Grigorieff N (2007) FREALIGN: high-resolution refinement of single particle structures. J Struct Biol 157: 117-125.
66. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al. (2004) UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25: 1605-1612.
67. Ludtke SJ, Baldwin PR, Chiu W (1999) EMAN: semiautomated software for high-resolution single-particle reconstructions. J Struct Biol 128: 82-97.